Navigation Links
Dartmouth researchers get personal with genetics
Date:9/15/2009

HANOVER, NH Two recent studies by Dartmouth researchers use individual genetic data to reveal the powers and limits of our current understanding of how the genome influences human health and what genes can reveal about the ancestry of the people of New Hampshire.

Published in the Sept. 11 issue of the American Journal of Human Genetics, Dartmouth Professor Jason Moore and Vanderbilt Professor Scott Williams analyzed how personal genetic testing companies are using still-nascent genome data to judge the health of their customers. Their paper is titled "Epistasis and its Implications for Personal Genetics."

People can now buy inexpensive kits, submit a DNA sample (often a swab from the inside of a cheek or a little bit of saliva), and receive data about their susceptibility to a number of gene-influenced ailments, such as prostate cancer, Alzheimer's, or type II diabetes. Moore and Williams argue that our knowledge of the human genome and its relationship to human health, while growing by leaps and bounds, is still in its infancy.

"The relationship between health and genetics is very complex," says Moore, professor of genetics and of community and family medicine at Dartmouth Medical School (DMS). "It's often a combination of multiple genes and multiple environmental factors that work together to increase or decrease your risk of disease. I don't think the knowledge base is sufficient to put genetics in the hands of the public quite yet." Moore is also the Frank Lane Research Scholar in Computational Genetics and Director of Bioinformatics at DMS

The authors admit that genetic research is progressing, and they cite the example of the discovery of the BRCA1 and BRCA2 genes and their role in breast cancer. However, the authors caution that, while there is no question these genes are involved in breast cancer, the underlying mechanisms behind the genetic risk are still being worked out.

"There is a perception that these tests can provide answers," says Moore. "I used my own genetic material for this study, and my results didn't really tell me anything I didn't know, based on family history."

Moore and Williams call for refocusing and stepping up the research on gene-to-gene and gene-to-environment interactions. They explain that for many years, researchers have focused on single genes and clinical endpoints. The time has come, they say, to embrace rather than ignore the complexity of human traits as they are expressed by the whole genome working in concert.

"Although genetic testing for common human diseases is not yet useful, using genetic testing results to reveal an individual's ancestry is increasingly reliable," says Moore. He and PhD candidate Chantel Sloan recently mined some genetic data for a study that examined the population structure of New Hampshire residents.

Published in the September issue of PLoS ONE (a journal of the Public Library of Science), they study by Sloan and Moore and their colleagues analyzed more than 1,000 genetic markers from 864 people in New Hampshire. They discovered six subgroups of people with distinct genetic backgrounds including a group of Finnish and Russian/Polish/Lithuanian ancestry.

"I knew that people would be primarily European," says Sloan. "What I didn't expect was the strong connection between genetic structure and people of Eastern European ancestry, which I learned is consistent with New Hampshire census and immigration data from 1870 to 1930."

Sloan used data initially compiled for a cancer study, so the genetic markers were cancer susceptibility genes rather than known ancestral genes, and the population being analyzed was not racially or geographically distinct. The results challenge the assumption that large numbers of special genetic markers are needed to discover genetically distinct groups of people.

"This is an example of how personal genetic data can be used to help inform people of their ancestry," says Moore. "Informing people of their future health is still out of reach, though."


'/>"/>

Contact: Sue Knapp
sue.knapp@dartmouth.edu
603-646-3661
Dartmouth College
Source:Eurekalert

Related biology news :

1. Dartmouth researchers find new protein function
2. Dartmouth workshop sets research agenda for environmental mercury
3. Dartmouth awarded NSF grant for new polar sciences, engineering grad program
4. Dartmouth researchers identify an important gene for a healthy, nutritious plant
5. Dartmouth researchers discover gene signatures for scleroderma
6. Dartmouth researchers find the root of the evolutionary emergence of vertebrates
7. Dartmouth researchers alarmed by levels of mercury and arsenic in Chinese freshwater ecosystem
8. Dartmouth researchers show effects of low dose arsenic on development
9. Ecosystem researchers to hold science briefing for policymakers
10. UAB researchers looking for genetic predictors for suicide
11. Rice researchers seek better vaccine procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
(Date:1/22/2016)... , January 22, 2016 /PRNewswire/ ... announced the addition of the  "Global ... their offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... ... February 11, 2016 , ... Reichert Technologies, which ... today to pursue the highest level of accuracy and quality with the addition ... and the AR5 Refractometer. Accurate, reliable and tough enough for the most ...
(Date:2/10/2016)... BioAmber Inc. (NYSE: BIOA ), a leader in ... Co. Ltd., its partner in the Sarnia ... additional CDN$25 million in the joint venture for 10% ... 40%.  Mitsui will also play a stronger role in ... Sarnia , providing dedicated resources alongside BioAmber,s commercial ...
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
(Date:2/10/2016)... (NYSE MKT: ISR), a medical technology company and innovator ... treatment of prostate, brain, lung, head and neck and ... second quarter and six months of fiscal 2016, which ... --> Revenue was $1.19 million for ... 31, 2015, a 12% increase compared to $1.07 million ...
Breaking Biology Technology: